Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Aathavan Loganayagam"'
Autor:
Ahmed B. Bayoumy, Elsa L. S. A. van Liere, Melek Simsek, Ben Warner, Aathavan Loganayagam, Jeremy D. Sanderson, Simon Anderson, Jonathan Nolan, Nanne K. de Boer, Chris J. J. Mulder, Azhar Ansari
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Thioguanine (TG) is a thiopurine which has been used for patients with inflammatory bowel disease (IBD), who have failed azathioprine (AZA) or mercaptopurine (MP) due to adverse events or suboptimal response. Its widespread use ha
Externí odkaz:
https://doaj.org/article/bfe5395b29134036b42431b621fc1219
Autor:
Ahmed B. Bayoumy, Elsa L. S. A. van Liere, Melek Simsek, Ben Warner, Aathavan Loganayagam, Jeremy D. Sanderson, Simon Anderson, Jonathan Nolan, Nanne K. de Boer, Chris J. J. Mulder, Azhar Ansari
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/a7e0fdee6475429a81c58f908ebeb202
Autor:
Azhar Ansari, Paul J. Boekema, Jeremy D. Sanderson, Chris J. J. Mulder, Ahmed B. Bayoumy, Simon Anderson, Luc J J Derijks, Aathavan Loganayagam
Publikováno v:
Therapeutic Drug Monitoring, 43(5), 617-623. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring
Bayoumy, A B, Mulder, C J J, Loganayagam, A, Sanderson, J D, Anderson, S, Boekema, P J, Derijks, L J J & Ansari, A R 2021, ' Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine ', Therapeutic Drug Monitoring, vol. 43, no. 5, pp. 617-623 . https://doi.org/10.1097/FTD.0000000000000869
Therapeutic Drug Monitoring
Bayoumy, A B, Mulder, C J J, Loganayagam, A, Sanderson, J D, Anderson, S, Boekema, P J, Derijks, L J J & Ansari, A R 2021, ' Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine ', Therapeutic Drug Monitoring, vol. 43, no. 5, pp. 617-623 . https://doi.org/10.1097/FTD.0000000000000869
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gut. It can be divided into 2 main diseases: Crohn's disease (CD) and ulcerative colitis (UC). In the past 25 years, novel biological therapies have emerged for the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d91bff36457c63f2cc7e2087414107
https://research.vumc.nl/en/publications/8ab981e9-5851-49a7-8e73-096fa2e3e739
https://research.vumc.nl/en/publications/8ab981e9-5851-49a7-8e73-096fa2e3e739
Autor:
Chris J. J. Mulder, Simon Anderson, Nanne K. H. de Boer, Aathavan Loganayagam, Jonathan Nolan, Melek Simsek, Ahmed B. Bayoumy, Ben Warner, Elsa L. S. A. van Liere, Azhar Ansari, Jeremy D. Sanderson
Publikováno v:
Bayoumy, A B, van Liere, E L S A, Simsek, M, Warner, B, Loganayagam, A, Sanderson, J D, Anderson, S, Nolan, J, de Boer, N K, Mulder, C J J & Ansari, A 2020, ' Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease : a retrospective multi-centre study in the United Kingdom ', Bmc Gastroenterology, vol. 20, no. 1, pp. 296 . https://doi.org/10.1186/s12876-020-01441-6
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Gastroenterology
Bmc Gastroenterology, 20(1). BioMed Central
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Gastroenterology
Bmc Gastroenterology, 20(1). BioMed Central
Background Thioguanine (TG) is a thiopurine which has been used for patients with inflammatory bowel disease (IBD), who have failed azathioprine (AZA) or mercaptopurine (MP) due to adverse events or suboptimal response. Its widespread use has been ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c15deac05f1e20bb3de41ed48cea0919
https://research.vumc.nl/en/publications/705766b7-8586-4248-b0ff-935325e6f246
https://research.vumc.nl/en/publications/705766b7-8586-4248-b0ff-935325e6f246
Publikováno v:
Endoscopy.
Introduction Chronic diarrhoea is an indication for referral on the Colorectal two week wait (TWW) pathway for suspected malignancy. Microscopic colitis (MC) characteristically presents with chronic watery diarrhoea. The frequency of MC diagnosed in
Autor:
Paul Ross, Anthony M. Marinaki, Jeremy D. Sanderson, Lynette D. Fairbanks, Aathavan Loganayagam, Monica Arenas-Hernandez
Publikováno v:
Cancer Chemotherapy and Pharmacology. 65:403-406
The fluoropyrimidines have been extensively used for almost five decade worldwide for the treatment of solid cancers. However, severe toxicity is a major clinical problem and has been reported in association with deleterious sequence variants in dihy
Autor:
Cathryn M. Lewis, M. Arenas Hernandez, Nick Maisey, Anthony M. Marinaki, Peter Harper, Jeremy D. Sanderson, Lynette D. Fairbanks, Aathavan Loganayagam, Paul Ross, A. Corrigan
Publikováno v:
British Journal of Cancer
Background: Fluoropyrimidine drugs are extensively used for the treatment of solid cancers. However, adverse drug reactions are a major clinical problem, often necessitating treatment discontinuation. The aim of this study was to identify pharmacogen
Publikováno v:
British journal of hospital medicine (London, England : 2005). 73(9)
This article presents a case of a patient with undiagnosed ulcerative colitis who presented with autoimmune haemolytic anaemia.
Publikováno v:
British Journal of General Practice. 64:595-596
One in 10 patients attends general practice with gastrointestinal symptoms.1 Irritable bowel syndrome (IBS) is typified by abdominal discomfort or pain, and bloating with disturbed defecation.2 It affects 10–20% of the general public,2 but it is di
Publikováno v:
Journal of Hospital Medicine. 5